TY - JOUR AB - Coronavirus disease 2019 (COVID‑19) is a newly emerging infectious disease caused by the novel coronavirus SARS‑CoV‑2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID‑19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue. Due to its highly infectious nature it rapidly led to widespread human infection, causing 80,924 confirmed cases and 3,140 mortalities in mainland China as of March 9, 2020. The present review highlights the prevalence of COVID‑19 in China, the etiology, pathology, clinical presentation, laboratory and chest imaging tests, and treatment of this disease. AD - Department of Infectious Diseases, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong 518020, P.R. China State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China AU - Chen,Hongtao AU - Wu,Shipin AU - Zhang,Xiaoyong DA - 2020/12/01 DO - 10.3892/etm.2020.9353 IS - 6 JO - Exp Ther Med KW - COVID‑19 coronavirus epidemiology pathology treatment PY - 2020 SN - 1792-0981 1792-1015 SP - 223 ST - COVID‑19 in China: From epidemiology to treatment (Review) T2 - Experimental and Therapeutic Medicine TI - COVID‑19 in China: From epidemiology to treatment (Review) UR - https://doi.org/10.3892/etm.2020.9353 VL - 20 ER -